Company Filing History:
1 out of 39 
1 out of 5 
1 out of 149 Years Active: 1998-2016
Title: The Innovations of Michael Mach
Introduction
Michael Mach is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of human cytomegalovirus research. With a total of 4 patents to his name, Mach's work has the potential to impact medical treatments and therapies.
Latest Patents
One of his latest patents focuses on binding members for human cytomegalovirus. This invention relates to antibody molecules that can neutralize the biological effects of human cytomegalovirus (hCMV). These binding members may prove useful for the treatment and prophylaxis of hCMV infection. Another significant patent involves the structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), detailing its preparation and use.
Career Highlights
Throughout his career, Michael Mach has worked with several prominent companies, including Behring Diagnostics GmbH and 4-Antibody AG. His experience in these organizations has allowed him to develop innovative solutions in the field of virology.
Collaborations
Mach has collaborated with notable colleagues such as Gerhard Jahn and Birgit-Christine Scholl, contributing to advancements in their shared field of expertise.
Conclusion
Michael Mach's contributions to the field of biotechnology, particularly in relation to human cytomegalovirus, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options.